ArticleOrthopaedic surgery2025
Efficacy Analysis of Arthroscopic Treatment of Synovial Chondromatosis of the Knee: A Retrospective Study of More Than Five Years.
Article in Orthopaedic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Advanced arthroscopic management of diffuse knee synovial chondromatosis with large tricompartmental nodules using trans-notch visualization and a safe posteromedial portal.International journal of surgery case reports · 2026Article
- Synovial Chondromatosis: A Narrative Review of Current Evidence on Diagnosis, Differential Diagnosis, and Management.Medicina (Kaunas, Lithuania) · 2026Review
- Recurrent knee pain and effusion in a child: synovial chondromatosis.BMJ case reports · 2026Article
- Efficacy Analysis of Arthroscopic Treatment of Synovial Chondromatosis of the Knee: A Retrospective Study of More Than Five Years.Orthopaedic surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveThe synovial chondromatosis is an exceptionally rare benign condition, predominantly found in the knee joint, and can result in pain, restricted mobility, and potential irreversible damage to the joint and cartilage. Despite the utilization of arthroscopic techniques in the surgical management of synovial chondromatosis, there remains a paucity of long-term assessment regarding its efficacy. The main objectives of this study include: (i) investigating the long-term efficacy of arthroscopic surgery in patients with knee synovial chondromatosis;(ii) identifying factors influencing functional improvement in patients post-surgery function.
methodsWe conducted a retrospective analysis of all patients with synovial chondromatosis of the knee who underwent arthroscopic synovectomy and loose body removal at our institution between June 2009 and January 2020. The follow-up period for all cases exceeded 5 years. Data collection included demographic details, clinical efficacy indicators(VAS, KOOS, WOMAC, etc.), imaging findings, and subjective satisfaction of patients with surgical outcomes. Data analysis selected t-tests, ANOVA, non-parametric tests, and correlation methods based on normality test results.
resultsWe enrolled a total of 13 patients, including 4 men and 9 women, with a mean follow-up of 113.15 ± 30.45 months (range 61-145). There were no postoperative complications, recurrence, or malignant transformation in all patients, and the VAS scores, KOOS scores, WOMAC scores, and Lysholm scores of all patients were significantly improved at 3 months, 6 months, 1 year, 5 years, and the last follow-up (p < 0.05). However, one patient experienced osteoarthritis progression, necessitating arthroplasty.
conclusionThis retrospective study demonstrated that arthroscopic treatment for knee synovial chondromatosis is effective and safe. It leads to immediate post-intervention improvement in symptoms and function, with sustained long-term benefits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.